Coherus BioSciences Inc (NAS:CHRS)
$ 1.02 -0.11 (-9.73%) Market Cap: 117.51 Mil Enterprise Value: 227.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Q3 2022 Coherus BioSciences Inc Earnings Call Transcript

Nov 08, 2022 / 10:00PM GMT
Release Date Price: $7.99 (+2.17%)
Operator

Good day, and thank you for standing by. Welcome to the Coherus BioSciences, Inc. Q3 2022 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Marek Ciszewski, Senior Vice President of Investor Relations. Marek, please go ahead.

Marek Ciszewski

Thank you, Rael. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier today announcing our financial results for the third quarter of 2022. This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K.

Today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include, but are not limited to, our ability to gain approval for multiple new products and launch them, timing of the end of our decline in revenue and timing of our ability to gain market share for any of our approved products, expectations about revenue growth, projections of expenses and revenue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot